Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany

Background: The incidence of therapy-related acute leukaemia (TRAL) in mitoxantrone treatment in multiple sclerosis (MS) is controversially discussed. Methods and results: In a retrospective meta-analysis from six centres, we observed six cases of acute myeloid leukaemia (AML) (incidence 0.41% for p...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Stroet, Anke, Hemmelmann, Claudia, Starck, Michaela, Zettl, Uwe, Dörr, Jan, Paul, Friedemann, Flachenecker, Peter, Fleischer, Vinzenz, Zipp, Frauke, Nückel, Holger, Kieseier, Bernd C, Ziegler, Andreas, Gold, Ralf, Chan, Andrew
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2012
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3302202/
https://ncbi.nlm.nih.gov/pubmed/22435072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285611433318
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items